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Abstract 
Protein transport across the cytoplasmic 
membrane of bacterial cells is mediated by either 
the general secretion (Sec) system or the twin 
arginine translocase (Tat). The Tat machinery 
exports folded and cofactor containing proteins 
from the cytoplasm to the periplasm by using the 
transmembrane proton motive force as a source 
of energy. The Tat apparatus apparently senses 
the folded state of its protein substrates, a quality 
control mechanism that prevents premature 
export of nascent unfolded or misfolded 
polypeptides, but its mechanistic basis has not 
yet been determined. Here, we investigated the 
innate ability of the model Escherichia coli Tat 
system to recognize and translocate de novo-
designed protein substrates with experimentally 
determined differences in the extent of folding. 
Water-soluble, four-helix bundle maquette 
proteins were engineered to bind two, one or no 
heme b cofactors, resulting in a concomitant 
reduction in the extent of their folding, assessed 
with temperature-dependent CD spectroscopy 
and one-dimensional 1H NMR spectroscopy. 
Fusion of the archetypal N-terminal Tat signal 
peptide of the E. coli trimethylamine-N-oxide 
(TMAO) reductase (TorA) to the N-terminus of 
the protein maquettes was sufficient for the Tat 
system to recognize them as substrates. The clear 
correlation between the level of Tat-dependent 
export and the degree of heme b-induced folding 
of the maquette protein suggested that the 
membrane-bound Tat machinery can sense the 
extent of folding and conformational flexibility 
of its substrates. We propose that these artificial 
proteins are ideal substrates for future 
investigations of the Tat system’s quality control 
mechanism.  
 
Introduction 
 The transport of proteins across 
membranes is one of the great challenges faced 
by the cell. In prokaryotes, two major pathways 
are used to achieve protein translocation across 
the cytoplasmic (inner) membrane. The general 
Secretion (Sec) pathway transports proteins in an 
unfolded configuration using energy provided 
by both ATP hydrolysis and the transmembrane 
proton gradient (1). In contrast, the Twin 
arginine translocase (Tat) system transports fully 
folded proteins (2, 3) and is energized solely by 
the transmembrane proton gradient. 
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The majority of Tat substrates are 
cofactor-containing proteins that require 
assembly in the cytoplasm (4-6) including those 
that fold too quickly for Sec transport (7) and 
those that assemble into oligomeric complexes 
(8). Proteins translocated by the Tat pathway 
have an N-terminal signal sequence 
characterized by a twin arginine (RR) motif (9); 
the signal sequence is cleaved from the precursor 
protein during or immediately after 
translocation, releasing the mature protein into 
the periplasm. 
 How components of the Tat machinery 
assess the folding state of a protein substrate 
remains poorly understood (6, 10, 11). Many 
studies have attempted to prove the presence of 
a quality control or proofreading mechanism that 
exists to prevent futile export of misfolded or 
misassembled proteins (12-14). In Escherichia 
coli the Tat apparatus comprises TatA/B family 
proteins and the TatC protein. Single point 
mutations in either TatA or TatC were identified 
that allow translocation of unfolded substrates, 
and point mutations in both TatB and TatC 
enabled export of a broader range of unfolded 
substrates, suggesting that the TatABC subunits 
cooperatively assess the folding state of proteins 
independently of protein translocation (15). 
Richter et al. (16) showed that small, 
unstructured hydrophilic FG repeat proteins 
could be exported by the Tat system, and that the 
presence of hydrophobic surface patches was 
sufficient to abort transport, raising the 
possibility that the Tat system screens proteins 
based on their surface hydrophobicity. It has 
been reported that the length of the unstructured 
FG repeat polypeptide dramatically affects Tat 
export, with longer regions abolishing Tat export 
altogether (17). Conversely, Jones et al. (18) 
recently reported that the Tat system was 
surprisingly tolerant of hydrophobic patches on 
the surface of structured single-chain variable 
fragment proteins, and export efficiency was 
increased with greater structural rigidity. 
Chaperones may also prevent export of a protein 
until cofactor insertion has taken place (19-21), 
and mutants incapable of cofactor binding are 
rapidly degraded once in contact with the Tat 
machinery (22). 
 In order to further investigate the Tat 
quality control mechanism, we used maquettes, 
which are simple, repetitive protein structures 
designed de novo from first principles with 
minimal reference to natural protein structures 
(23-26). As natural protein structures contain 
unnecessary complexity, accumulated from 
perpetual rounds of blind natural selection (27), 
altering protein residues can have unpredictable 
effects on protein structure and dynamics. In 
contrast, the role of each amino acid in the 
simple maquette structure has been rationalized 
at the outset, so changes to structure and function 
become more predictable. 
The maquettes used in this study are 
based on the BT6 maquette developed by Farid 
et al. (28), and consist of loops linking four 
largely identical α-helices enclosing a water-
excluding cavity that can accommodate 
cofactors (Fig. 1A-C). Histidine residues within 
the maquette cavity ligate hemes, producing 
artificial proteins resembling b-type 
cytochromes and myoglobin (29, 30). 
Here, three different maquette variants 
were utilized, each with a different heme b 
binding capacity (Fig. 1). Using nuclear 
magnetic resonance (NMR) and circular 
dichroism (CD) spectroscopy we show that 
binding 2, 1 or 0 hemes (Fig. 1A, B, C, 
respectively) imparts changes in the extent of 
folding of the maquette variants. The archetypal 
trimethylamine N-oxide reductase (TorA) Tat 
signal peptide was fused to the N-terminus of the 
three proteins and the E. coli Tat machinery was 
challenged to differentiate between the folding 
variants. We show that the Tat apparatus is able 
to sense the conformational flexibility of the 
different maquette substrates, and that 
increasingly well-folded maquettes are exported 
with enhanced efficiency. 
 
Results 
Production of heme-reconstituted 
maquettes–The aim of this study was to test 
whether the E. coli Tat system could recognize 
and export a de novo designed di-heme protein, 
and then to use variants of this protein with 
experimentally confirmed differences in 
conformational flexibility to test if the Tat 
apparatus selectively processes the more folded 
proteins. 
As described above and depicted in the 
computationally-generated structures presented 
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in Fig. 1, three variants of the BT6 maquette 
were produced, facilitating the incorporation of 
2 (BT6), 1 (BT6M1) or 0 (BT6M0) heme b 
cofactors. The requirement for bis-histidine 
ligation of heme b in the artificial constructs 
enabled the generation of the 1 and 0 heme 
binding variants through H53A, and 
H53A/H88A (histidine to alanine) point 
mutations, respectively (Table 1). The 
computational models in Fig. 1 extend the 
theoretical structure of the BT6 maquette 
outlined by Farid et al (28). They are included to 
illustrate the apo- and heme-maquette designs 
used as Tat substrates, and are not intended as a 
replacement for atomically-accurate 
experimental structures. 
Maquettes are typically overproduced in 
E. coli in large amounts, with bound heme 
largely absent following purification (see 
Materials and Methods) because the native 
tetrapyrrole biosynthesis pathway cannot keep 
pace with the induced synthesis of maquette 
(Fig. S1A). Apo-proteins were reconstituted in 
vitro with an excess of heme and unbound 
pigment was removed by anion exchange 
chromatography. The Soret absorption bands for 
the BT6, BT6M1 and BT6M0 maquettes were 
normalized for protein concentration 
(absorbance at 280 nm) and had maxima at 413 
nm, 412 nm and 396 nm, respectively (Fig. 2A), 
with the amplitudes corresponding to binding 2, 
1, and 0 hemes, respectively. The weak, blue-
shifted absorption for the BT6M0 maquette 
suggested a low level of adventitiously bound 
heme. We compared heme absorption in the 
maquette-bound, and solvated (buffer or 
dimethyl sulfoxide, DMSO) states which had 
respective maxima at 413 nm, 404 nm and 384 
nm (Fig. S1B). The blue-shifted absorption 
maxima for solvated heme are consistent with 
the weak, blue-shifted absorption for BT6M0 
(Fig. 2A) arising from residual, weakly bound 
heme; ligation into the internal cavity of BT6 
and BT6M1 causes a red-shift absorption of the 
heme. 
Thermostability and folding of maquette 
variants–Temperature-dependent CD 
spectroscopy was performed to assess the effect 
of heme ligation on the thermal stability of each 
maquette scaffold. At 15 °C the CD spectra of all 
three maquette variants, with or without bound 
heme, were typical of α-helical structures (Fig. 
S2, black lines). Likewise, irrespective of heme 
binding heating to 80 °C resulted in spectra 
typical of that of a denatured protein (31) (Fig. 
S2 from black to red to grey lines).  
Ellipticity at 222 nm was monitored 
during temperature cycling from 15 to 80 to 15 
°C to observe denaturing and subsequent re-
folding of protein (Fig. 2B-D). For BT6, heme 
incorporation displaced the midpoint of the 
melting curve from 22 °C to 56 °C, the 34 °C 
difference indicating increased stabilization 
following heme binding. The same procedure 
with BT6M1 increased stabilization by only 16 
°C (25 °C to 41 °C), and had very little effect on 
the BT6M0 scaffold (32 °C to 35 °C) (Table 2). 
Thus, bis-histidine ligation of two hemes within 
the maquette cavity of BT6 significantly 
stabilizes the four-helix bundle structure, and 
there is a smaller effect with only one bis-
histidine ligation in BT6M1. In the case of 
BT6M0, where heme ligation is not possible, 
there is correspondingly no significant 
stabilization of maquette structure in the 
presence of heme. 
One-dimensional proton (1H) NMR 
spectroscopy was used to assess conformational 
changes in tertiary structure upon heme binding 
to maquettes. A 1H NMR spectrum characteristic 
of a protein with limited tertiary structure was 
observed for all maquette scaffolds in the 
absence of heme (Fig. 3A, S3). Addition of heme 
to BT6 showed greater dispersion of resonances 
in the amide proton region, with a notable 
increase in the number of peaks at around 10 
ppm, suggesting that the heme is binding to the 
scaffold and stabilizing the protein tertiary 
structure (Fig. 3B).  BT6M1 showed a small 
increase in resonance dispersion following heme 
addition (Fig. 3C), whilst BT6M0 showed no 
significant change in amide proton dispersion 
(Fig. 3D). The increase in the chemical shift 
dispersion observed in the methyl proton region 
(at around 1.0-0.0 ppm) for BT6, BT6M1, and 
BT6M0 mirrored the behavior observed for the 
amide proton resonances (Fig. S4). Together, the 
increase in 1H NMR dispersion in both backbone 
amide and methyl regions, confirm the ligation 
of heme into the BT6 and BT6M1 variants and 
indicate an increase in protein folding upon 
ligation. These results are consistent with a 
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previous NMR study that showed poor 
dispersion for a related apo maquette, and 
progressive structuring of the maquette iwhen 
one then two equivalents of heme were added 
(28).  
In vivo Tat export assays–The E. coli 
TorA signal peptide is sufficient to direct green 
fluorescent protein (GFP) to the E. coli 
periplasm via the Tat system (13). Constructs in 
which the sequence encoding the TorA signal 
peptide (residues 1-39) and first four amino acids 
of the mature TorA protein (residues 40-43) 
were added in-frame to the 5’terminus of the 
genes encoding the BT6 maquette variants 
followed by a C-terminal 6хHis tag (Fig. S5) 
were synthesized and cloned into the pEXT22 
vector (Table S1). In the TorA-BT6 variants 
residues H95 and H130 correspond to H53 and 
H88 in the maquette scaffolds presented in Fig. 
1.  
The resulting plasmids were co-
transformed into E. coli BL21 (DE3) along with 
empty pET-21a(+). The pEXT22 vector was 
used as it allows isopropyl β-D-1-
thiogalactopyranoside (IPTG) inducible 
expression of the synthetic gene under the 
control of a tightly regulated tac promoter. The 
low copy number of pEXT22 (R100 origin of 
replication, 1-1.5 copies per chromosome) (32, 
33) limits production of recombinant protein, to 
avoid overwhelming the E. coli Tat apparatus 
with substrate.  
Following growth and protein 
production, periplasmic fractions were prepared 
from harvested cells as described in Materials 
and Methods and analyzed alongside cell-free 
extracts prepared from identically grown cells. 
The C-terminal 6хHis tag allows 
immunodetection of the recombinant protein; 
the predicted molecular weight of the 
unprocessed precursor protein is ~21 kDa while 
the Tat-processed mature protein is ~17 kDa. 
Anti-GroEL was used in order to probe the 
degree of cytoplasmic contamination in our 
periplasmic preparations (Fig. 4A); for all 
samples only a faint signal was detectable in the 
periplasm compared to that detected in cell free 
extracts, indicating the level of contamination 
was very low. The Tat export assays were 
performed in cells which also maintained the 
pET-21a(+) vector, allowing immunoblot 
signals to be normalized by immunodetection of 
β-lactamase (Fig. 4B), allowing direct 
comparison of the degree of Tat transport 
between samples. 
For TorA-BT6, a 17 kDa signal was 
present for both periplasmic and cell free extract 
(Fig. 4C) preparations with no signal detected at 
21 kDa, indicating complete processing and 
export of TorA-BT6. To confirm the periplasmic 
localization was Tat-dependent, a R12K/R13K 
(KK) variant of the TorA signal peptide was 
generated and fused to BT6 (Table 1); it has 
previously been demonstrated that the KK 
change completely abolishes Tat-transport (12, 
34). When this construct was tested, a 21 kDa 
signal corresponding to the unprocessed apo 
protein is observed in blots of total lysates and 
no processed protein was detectable in the 
periplasm (Fig. 4C). Together these data indicate 
that the BT6 scaffold is able to acquire heme 
from the native biosynthetic pathway and fold in 
vivo, and that this folding event can be detected 
by the Tat system, with the TorA signal peptide 
sufficient for Tat-mediated recognition and 
transport of heme-loaded BT6 to the E. coli 
periplasm. 
To probe the proofreading ability of the 
Tat machinery to recognize and efficiently 
export only folded proteins, similar constructs 
were generated in which the TorA signal peptide 
was fused to the BT6M1 and BT6M0 maquettes, 
which, in the presence of heme, are either 
partially folded (BT6M1) or unfolded (BT6M0) 
relative to BT6 (Figs. 2 and 3). Compared to 
BT6, considerably less protein was found in the 
periplasm for BT6M1, and almost no signal for 
BT6M0 (Fig. 4C). Conversely, blots of cell free 
extracts of the same strains reveal a significant 
signal for the unprocessed maquettes for 
BT6M0, and to a lesser extent BT6M1, as 
observed for the to the TorA-KK-BT6 control, 
showing that the pre-protein accumulates in the 
cytoplasm when it is less well folded (Fig. 4B).  
The cellular levels of maquette variants 
should be very similar as all the proteins are 
identical apart from 1 or 2 point mutations and 
were expressed from the same plasmid in the 
same cell line under the same conditions. Indeed, 
the data presented in Fig. 4C shows that the total 
signal (preprotein plus exported protein where 
relevant) for all three maquettes is similar. 
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However, to further confirm that the differential 
periplasmic targeting of the three BT6 variants 
by the Tat system was due to differences in their 
heme loading and associated folding and not in 
expression, synthesis or stability, we performed 
two additional control experiments.  
First we produced each maquette under 
the same conditions as for the Tat export assays 
but without the TorA signal peptide, and 
immunoblotting confirmed approximately equal 
levels of each (Fig. S6A), ruling out that BT6M1 
and BT6M0 are produced at lower levels or are 
more rapidly degraded in the cytoplasm than 
BT6.  
We also performed Sec-system 
mediated export assays of BT6, BT6M1 and 
BT6M0. As the Sec system transports unfolded 
proteins across the cytoplasmic membrane, 
differences in folding, mediated in the case of 
BT6 by heme binding, will not affect transport. 
Maquette genes were cloned into the pET-
22b(+) vector (Table S1) in frame with an N-
terminal PelB (Erwinia carotovora pectate lyase 
B) Sec leader peptide (22 amino acids) (35, 36) 
(Table 1). Stop codons were omitted so proteins 
had a C-terminal 6хHis tag for 
immunodetection; the unprocessed proteins have 
a predicted molecular weight of approximately 
19 kDa and the mature maquettes would be 
approximately 17 kDa following cleavage of the 
PelB signal sequence. Fig. S6B shows that when 
normalized amounts of cell lysates were loaded 
that single, similarly intense signals were 
detected for BT6, BT6M1 and BT6M0, 
indicating all three apo-maquettes are equally 
synthesized and transported to the periplasm 
when directed through the Sec system.  
Purification of maquettes from the 
periplasm–To demonstrate that heme ligation-
into BT6 was responsible for its Tat-dependent 
localization in the periplasm, production of His-
tagged maquettes was performed on a larger 
scale using the recently described E. coli 
W3110-TatExpress cell line (37). Cells were 
fractionated and maquette proteins were purified 
from the periplasmic fraction by immobilized 
metal affinity chromatography (IMAC). IMAC 
eluates were concentrated and striking 
differences in pigmentation between the 
maquette variants were observed, with a deep 
red color for BT6, weaker pigmentation for 
BT6M1, and no visible color for BT6M0 (Fig. 5 
inset panels). SDS-PAGE of the concentrated 
eluates revealed the same pattern as the Tat 
exports presented in Fig. 4, with more BT6 than 
BT6M1 and only a trace amount of BT6M0 (Fig. 
S7). This also ruled out any leakage of 
unprocessed protein across the cytoplasmic 
membrane as the larger precursor species were 
not purified (Fig. S7). The absorbance spectra of 
Tat-exported BT6, BT6M1 and BT6M0 samples 
normalized at 280 nm are shown in Fig. 5, along 
with an in vitro heme reconstituted maquette. 
There is a close match between the spectra of the 
Tat-exported heme-loaded BT6 purified from 
the periplasm and the reconstituted BT6 sample 
(Fig. 5 solid red versus dashed red lines). The 
high affinity of BT6 for heme (28) ensures full 
occupancy of the two heme binding sites, so the 
Tat-transported BT6 purified from the periplasm 
is also fully heme bound.  
These data, alongside the export assays 
shown in Fig. 4, reveal that the artificial TorA-
BT6 maquette is able to sequester heme b from 
the native E. coli biosynthetic pathway, correctly 
fold around its substrate, and retain the pigment 
following export by the Tat-apparatus. 
 
Discussion 
The Tat pathway is present in the 
cytoplasmic membranes of most prokaryotic 
organisms and is evolutionarily conserved in the 
thylakoids of plant chloroplasts and some 
mitochondrial membranes (reviewed in Refs. 3 
and 7). As well as a biosynthetic role in 
numerous important cellular processes, the Tat 
pathway is required for colonization and 
virulence of globally significant human 
pathogens (38, 39). The Tat system differs from 
the universally conserved Sec pathway, which 
translocates unstructured polypeptides, as it 
transports folded, and typically cofactor 
containing, proteins. How the Tat apparatus is 
able to determine that a protein is folded, co-
factor loaded, and suitable for export is not 
understood.  
Here, we have used artificial heme 
‘maquette’ proteins to investigate the ability of 
the archetypal E. coli Tat machinery to 
discriminate between folding states of protein 
substrates. The maquettes used in this study are 
four-helix bundle proteins enclosing a 
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hydrophobic cavity that can accommodate heme 
cofactors ligated by histidine residues. Point 
mutations to the BT6 maquette, affecting only 
single histidine ligands, generated the BT6M1 
and BT6M0 maquettes, and were sufficient to 
reduce the number of bound hemes, verified by 
absorption spectroscopy (Fig. 2a). The number 
of bound hemes therefore provides a simple, 
well-defined method to alter the stability of a 
protein substrate. The consequent effects of 
heme content on the thermostability and folding 
of each maquette were measured using 
temperature-dependent CD spectroscopy (Fig. 
2b, Table 2) and 1H NMR (Fig. 3).  
When directed for export through the 
Tat export machinery of E. coli there were clear 
differences in the extent of translocation for 
BT6, BT6M1 and BT6M0 maquettes (Fig. 4) 
that correlate with the in vitro stability and 
folding experiments for heme-bound constructs. 
Export efficiency decreased with increasing 
conformational flexibility; the unstructured 
BT6M0 maquette is largely rejected for export, 
while limited export was observed in the 
intermediate case of the single heme-binding 
BT6M1 maquette.  
The export data shown would only be 
obtained if the BT6 maquettes were able to ligate 
heme, in vivo, produced by the native 
biosynthetic pathway of E. coli, as heme 
coordination is a pre-requisite for protein 
stability and folding. Evidence for in vivo heme 
ligation was shown with the purification of 
heme-containing maquettes from the 
periplasmic fraction of E. coli (Fig. 5), the 
spectra of which strongly resemble those of 
heme proteins generated in vitro (Fig. 2a). 
Although the native E. coli Tat 
translocase will never have encountered the 
artificial protein substrates described here, our 
data show that it is able to recognize and 
distinguish between them, even to the extent of 
processing the intermediate state BT6M1 
differently from the folded BT6 and the least 
structured BT6M0. Thus, the Tat proofreading 
process must involve a generic form of 
discrimination; the correlation between the 
structural flexibility of the Tat substrate and its 
suitability for export suggests that there are 
initial encounters between Tat components and 
the substrate at the membrane surface. Such 
interactions might sense flexible motions of the 
substrate that are transmitted to other 
components of the Tat machinery, preventing 
transport across the membrane. 
This proof-of-concept study shows that 
an artificial protein, engineered to bind heme b 
from a native biosynthetic pathway, can be 
exported from the cell in its correctly folded, 
functional state. Development of this concept 
may contribute a significant advance in 
biotechnology, where the principle could be 
applied to other organisms and to important 
biomolecules and protein-cofactor complexes, 
particularly those that may cause toxicity to the 
host. 
 
Experimental procedures 
Computational prediction and 
molecular dynamics refinement of protein 
structures–To generate illustrative structural 
models for BT6, the amino acid sequence was 
run through the PEP-FOLD structure prediction 
algorithm (40) for a total of 100 simulations, 
from which the five best-scoring structures were 
selected for further analysis. All five structures 
were four-helix bundles in agreement with the 
schematic structure described by Farid et al. 
(28). From these, a structure with both pairs of 
histidines positioned closest to their respective 
heme-ligating positions was selected as a 
starting structure. From this structure, mutants 
BT6M1 and BT6M0 were generated using 
PyMol v1.7 (PyMol Molecular Graphics System 
Version 1.7, Schrödinger, LLC).  Hemes (0, 1 or 
2) were manually docked into the bis-his sites of 
the structures. 
To relax the starting structure into an 
energy minimized conformation, molecular 
dynamics (MD) preprocessing, production runs, 
and post-processing were performed with 
Gromacs v4.6 (41). MD simulations were 
performed using the CHARMM27 Force Field 
for proteins and TIP3P-CHARMM model for 
water. For the heme cofactor, parameters were 
used for reduced, deprotonated, bis-his ligated 
heme included in the Charmm27 force field. 
Covalent bonds were explicitly specified 
between the heme iron and the epsilon nitrogen 
of the relevant histidine residues. NaCl was 
added to a total concentration of 150 mM. Each 
structure was equilibrated for 100 ps in the NVT 
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ensemble, followed by 100 ps in the NPT 
ensemble. Temperature and pressure/density 
plots (following NVT and NPT equilibrations, 
respectively) were checked for convergence 
before proceeding to production MD runs of 50 
ns. Following production runs, trajectories were 
corrected for periodicity and centered on the 
protein. Snapshots of the trajectories at 50 ns 
were exported to pdb files. Electrostatics and 
solvent accessible surface calculations were 
performed using APBS (42). Visualization of 
calculations and structures was performed with 
the PyMol Molecular Graphics System Version 
1.7, Schrödinger, LLC. 
DNA manipulation–Plasmids and 
primers used in this study are provided in Tables 
S1 and S2, respectively. Synthetic genes 
encoding maquette protein variants codon 
optimized for expression in E. coli were 
purchased from DNA2.0 (now ATUM) or 
Integrated DNA Technologies. Point mutations 
were generated using the QuikChange II Site-
Directed Mutagenesis Kit (Agilent). The TorA 
Tat signal peptide was amplified from E. coli 
genomic DNA and joined in frame to maquette 
constructs by overlap extension (OLE)-PCR 
using Q5 High-Fidelity DNA Polymerase 
(NEB). All plasmids were sequence verified by 
automated DNA sequencing (GATC Biotech). 
Competent E. coli JM109 (Promega) was used 
for cloning and was grown in Luria-Bertani (LB) 
broth/agar supplemented with the appropriate 
antibiotic(s) (Table S1). 
Production and purification of untagged 
maquettes–The high copy number pJexpress414 
plasmid was used for recombinant protein 
production under the control of an IPTG 
inducible T7 promoter. Escherichia coli 
BL21(DE3) containing the desired plasmid was 
grown with shaking (230 rpm) at 37 °C in LB 
broth with 100 µg ml-1 ampicillin to an optical 
density at 600 nm (OD600) of ~0.6. At this point 
IPTG was added to a final concentration of 1 
mM to induce expression and the cultures were 
incubated for a further 16 h at 37 °C. Cells were 
harvested by centrifugation (4,400 xg, 15 min, 
4°C) and resuspended in buffer A (50 mM 
HEPES pH 7.4, 500 mM NaCl, 5 mM 
imidazole). Cells were lysed by sonication on ice 
and the lysate was clarified by centrifugation 
(53,000 xg, 30 mins, 4°C). The supernatant was 
filtered through a 0.45 μm filter and applied to a 
Chelating Sepharose Fast Flow column (GE 
Healthcare) pre-equilibrated with 10 mg mL-1 
nickel sulfate. The column was washed with 5 
column volumes of buffer A with the flow-
through and wash collected and pooled. The 
pooled sample was buffer exchanged into buffer 
B (50 mM HEPES pH 7.4) and further purified 
by ion exchange chromatography (IEC) on a Fast 
Flow Q-Sepharose column (GE Healthcare) with 
a linear gradient of 0-1 M NaCl in buffer B. 
Where required maquettes were further purified 
by size exclusion chromatography on a Superdex 
200 increase column (GE Healthcare) in buffer 
C (50 mM HEPES pH7.4, 200 mM NaCl). 
Where necessary protein was concentrated using 
Vivaspin centrifugal concentrators (Sartorius). 
Heme reconstitution into apo-
maquettes–Hemin (Sigma-Aldrich) stocks (1 mg 
mL-1) were prepared in 100% DMSO. Protein 
concentrations were calculated by absorbance at 
280 nm following the method described by Gill 
and von Hippell (43), and using the 
experimentally determined (extinction 
coefficient of 32.6 mM-1 cm-1. Reconstitutions 
were conducted with a 10-fold molar excess of 
hemin in buffer D (50 mM HEPES pH 7.4, 200 
mM NaCl, 20 % (v/v) DMSO) and incubated for 
45 minutes at 25 °C, before being transferred to 
ice and buffer exchanged into buffer B using 
Vivaspin centrifugal concentrators. Unbound 
cofactor was removed by IEC on a DEAE 
Sepharose (Sigma Aldrich) column. 
UV-visible absorbance spectroscopy–
Protein samples were buffer exchanged into 
buffer E (5 mM sodium phosphate buffer pH 7.4) 
and UV-visible absorbance was measured in a 1 
cm path length polystyrene UV cuvette in a Cary 
60 UV-Vis spectrophotometer (Agilent) at room 
temperature.  
Circular dichroism spectroscopy–Mean 
residue ellipticity ([θ]MRW) of protein samples 
was measured in a 1 mm path length quartz 
cuvette on a Jasco J-810 spectropolarimeter with 
a Jasco PFD-425S Peltier to enable temperature 
control. Spectra were obtained from 15 °C to 80 
°C at 5 °C intervals. Spectra were recorded 
continuously at a scan speed of 100 nm min-1, 
with 1 nm resolution and a 4 s response with 4 
accumulations. Ellipticity ([θ]) at 222 nm was 
measured every 1 °C from 15 °C to 80 °C at 1 °C 
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min-1 with a 4 s response. Melting temperatures 
(Tm) and refolding temperatures (Tf) are the 
temperature at which 50% of the protein is 
unfolded or folded respectively as determined by 
fitting melting data to a sigmoidal Boltzmann 
distribution according to the following equation 
where T is the temperature, Tm is the melting (or 
folding) temperature and T0 is the initial 
temperature of the experiment.  
  
[𝜃]222nm = [𝜃]222nm
base +
(
 
 
 
 
[𝜃]222nm
max
1 + 𝑒𝑥𝑝
(
𝑇𝑚−𝑇0
𝜕𝑇
𝜕[𝜃]
)
)
 
 
 
 
 
 
Proton nuclear magnetic resonance 
spectroscopy–Spectra were recorded at 298 K on 
0.2-0.5 mM protein samples in buffer E, with the 
addition of 10% D2O (spectrometer lock), and 1 
mM trimethylsilylpropanate (TSP) (reference 
standard). 1H NMR spectra were recorded using 
a Bruker Avance 800 MHz spectrometer fitted 
with a 5-mm QXI room temperature probe, 
equipped with z-axis gradients. One-
dimensional experiments were acquired as 
accumulations of 4096 transients over a spectral 
width of 24.038 kHz, corresponding to a proton 
spectral width of 30.0 ppm. All data were 
processed using an EM window function and 5-
Hz line broadening, without linear prediction in 
TopSpin (Bruker). Spectra were referenced to 
TSP at 0 ppm prior to overlay and analysis.  
Escherichia coli fractionation–In order 
to avoid overloading the Tat system for in vivo 
transport assays, maquette genes were cloned 
into the KpnI and XbaI sites of the low copy 
number pEXT22 plasmid for expression from a 
tightly controlled tac promoter (33). The 
pEXT22 constructs (Table S1) were co-
transformed into E. coli BL21(DE3) cells along 
with empty pET-21a(+). Cultures (50 ml) were 
grown at 37°C with shaking (230 rpm) in LB 
medium with 30 µg ml-1 kanamycin and 100 µg 
ml-1 ampicillin in 250 mL Erlenmeyer flasks. At 
an OD600 of ~0.6 expression was induced with 
0.5 mM IPTG for 2 h. Cells were harvested by 
centrifugation (3,900 xg, 30 min, 4°C) and 
washed with buffer F (100 mM Tris-acetate pH 
8.2, 500 mM sucrose, 5 mM 
ethylenediaminetetraacetic acid (EDTA)). To 
prepare cell free lysates, cells were re-suspended 
to OD600 ~2 in 2 mL chilled Buffer C and lysed 
by sonication on ice. The supernatant, following 
clarification by centrifugation (16,600 xg, 30 
min 4°C), was collected as the cell-free lysate. 
Periplasmic fractions were obtained using a 
procedure based on the 
EDTA/lysozyme/osmotic shock method 
described by Randall and Hardy (44). Briefly, 
cells were re-suspended to OD600 ~10 in 500 µL 
chilled Buffer F followed by the addition of 5 μl 
of 1 mg ml-1 lysozyme. 500 μl of chilled QH2O 
was added and cells were incubated on ice for 5 
min prior to the addition of 20 µl 1 M MgSO4. 
Spheroplasts were pelleted by centrifugation at 
16,600 xg for 30 min in a pre-chilled (4°C) 
microcentrifuge and the supernatant was 
collected as the periplasm.  
Immunoblotting–Immunoblotting was 
performed essentially as described previously 
(45). Briefly, proteins were separated by SDS-
PAGE on 12% Bis-Tris gels (Invitrogen), 
transferred to polyvinylidene difluoride 
membranes (Invitrogen), and incubated with 
anti-6-His (Bethyl Laboratories, Inc.), anti-β-
Lactamase (Abcam) or anti-GroEL (Sigma-
Aldrich) primary antibodies followed by an 
appropriate horseradish peroxidase conjugated 
secondary antibody (Sigma-Aldrich). 
Chemiluminescence was detected using the 
WESTAR ETA C 2.0 chemiluminescent 
substrate (Cyanagen) on an Amersham Imager 
600 (GE Healthcare).  
Purification of Tat-exported proteins 
from E. coli periplasm–The E. coli W3110 
‘TatExpress’ cell line (37) was transformed with 
the pEXT22 vector containing either TorA-BT6, 
TorA-BT6M1 or TorA-BT6M0 (Table S1). 500 
mL cultures were grown in 2 L Erlenmeyer 
flasks at 30 °C with 220 rpm agitation. At an 
OD600 of ~0.6 protein production was induced 
with 0.5 mM IPTG and cultures were incubated 
for 24 h, after which cells were harvested by 
centrifugation (3,900 x g, 30 min, 4°C). To 
obtain periplasmic fractions, cells were 
resuspended in 10 mL chilled buffer F. 10 mL 
chilled QH2O was added followed by 800 µL 1 
mg mL-1 lysozyme and samples were incubated 
on ice for 10 min. 800 µL 1 M MgSO4 was added 
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and the solution was centrifuged (16,600 xg, 30 
min, 4°C) with the supernatant collected as 
periplasm. 
Periplasmic fractions were applied to a 
Chelating Sepharose Fast Flow column (GE 
Healthcare) pre-equilibrated with 10 mg mL-1 
nickel sulfate. The column was washed with 20 
mL of buffer A and 20 mL buffer G (50 mM 
HEPES pH 7.4, 500 mM NaCl, 50 mM 
imidazole). Protein was eluted with 10 mL 
buffer H (50 mM HEPES pH 7.4, 100 mM NaCl, 
400 mM imidazole) and the elution fractions 
were collected.
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Tables 
Table 1. Amino acid sequences of maquettes and signal peptides used in this study. 
Name Sequence* Details 
BT6 
 
MGGDGENLYFQG 
EIWKQHEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQHEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQHEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQHEDALQKFEEALNQFEDLK 
 
Di-heme binding 
BT6M1 
 
MGGDGENLYFQG 
EIWKQHEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQAEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQHEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQHEDALQKFEEALNQFEDLK 
 
Single heme binding due to removal of 
1 coordinating histidine residues 
BT6M0 
 
MGGDGENLYFQG 
EIWKQHEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQAEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQAEDALQKFEEALNQFEDLKQLGGSGSGSGG 
EIWKQHEDALQKFEEALNQFEDLK 
 
No heme binding due to removal of 2 
coordinating histidine residues 
TorA 
 
MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQAA 
 
TorA signal peptide for periplasmic 
localization by the Tat system 
 
TorA R12/13K 
 
MNNNDLFQASKKRFLAQLGGLTVAGMLGPSLLTPRRATAAQAA 
 
R12K/R13K TorA signal peptide 
 
PelB 
 
MKYLLPTAAAGLLLLAAQPAMA 
 
PelB signal peptide for periplasmic 
localization by Sec system 
 
*Heme coordinating histidine residues are shown in bold. The twin arginine motif of the Tat signal peptide is shown in bold italics.
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Table 2. Melting temperatures (Tm) and folding temperatures (Tf) of maquettes in the absence (apo) or presence of heme 
Maquette Apo +Heme 
Tm (oC) Tf (oC) Tm (oC) Tf (oC) 
BT6 22 17 56 54 
BT6M1 25 24 41 39 
BT6M0 32 32 35 36 
 
† The Tm and Tf (temperature at which 50% of the protein is unfolded or folded respectively) values are determined from Boltzman distribution fits 
as shown in Fig. 2B.  
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Figures 
 
Figure 1. Structural models of the BT6 maquette proteins used in this study. (A) BT6 (see ref. 28) coordinates two heme b molecules (red) 
using four histidine ligands (white). (B) In BT6M1 the H53A substitution means the protein can only coordinate 1 heme b. (C) In BT6M0 the double 
H53A/H88A substitution prevents heme binding. All images taken from 50 ns trajectories.
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Figure 2. Spectroscopic analysis of apo- and heme-reconstituted maquette proteins. (A) UV-visible absorption spectra of heme-reconstituted 
maquette samples normalized to absorbance at 280 nm. (B) – (D) Normalized melting (yellow) and refolding (green) of secondary structure measured 
as the reduction in circular dichroism ellipticity at 222 nm across a temperature gradient in the absence (open markers) or presence (solid markers) 
of heme. Elipticity was recorded ever 1 °C, but only ever 3 data points are shown for clarity. Lines are theoretical and described by a Boltzmann 
distribution (see Materials and methods). Melting (Tm) and refolding (Tf) temperatures are reported in Table 2. 
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Figure 3. Proton NMR resonances of maquettes with and without heme cofactor. The amide proton region (A) for apo-BT6 (red), apo-BT6M1 
(blue), and apo-BT6M0 (black), and comparisons in the absence (solid line) and presence (dashed line) of heme for BT6 (B), BT6M1 (C) and 
BT6M0 (D). For BT6 and BT6M1, the presence of heme induces changes in the amide proton resonance dispersion, whereas for BT6M0 negligible 
changes are observed. These chemical shift changes are consistent with a heme binding event coupled with a change in protein conformation 
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Figure 4. Differential export of BT6 variants by the Tat system determined by immunoblotting. (A) 
GroEL was used as a cytoplasmic marker to confirm only very minor cytoplasmic contamination of 
periplasmic preparations. (B) β-lactamase was used to confirm equal loadings of cell free extracts or 
periplasm samples. (C) The C-terminal His-tag on the BT6 maquettes was used to determine the degree of 
Tat-dependent periplasmic localization and the level of the unprocessed precursor proteins in cell free 
extracts.  For all panels the positions of molecular weight markers and the expected size of proteins are 
indicated alongside the blots. Each blot is representative of at least 3 independent experiments.  
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Figure 5. Spectroscopic analysis of purified maquette proteins. UV-visible absorbance spectra of 
maquettes purified from the periplasm of E. coli (BT6, red line; BT6M1, blue line; BT6M0, black line) 
compared to the BT6 reconstituted with hemin in vitro (red dashed line). Spectra are normalized to 
absorbance at 280 nm. Inset panels show the purified proteins. See Figure S7 for SDS-PAGE analysis of 
the purified maquettes.  
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